Cargando…

Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients

PURPOSE: The proliferation marker Ki-67 has been used as a prognostic marker to separate low- and high-risk breast cancer subtypes and guide treatment decisions for adjuvant chemotherapy. The association of Ki-67 with response to tamoxifen therapy is unclear. High-throughput automated scoring of Ki-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egeland, Nina Gran, Jonsdottir, Kristin, Lauridsen, Kristina Lystlund, Skaland, Ivar, Hjorth, Cathrine F, Gudlaugsson, Einar G, Hamilton-Dutoit, Stephen, Lash, Timothy L, Cronin-Fenton, Deirdre, Janssen, Emiel A M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383278/ https://www.ncbi.nlm.nih.gov/pubmed/32801916 http://dx.doi.org/10.2147/CLEP.S248167

Ejemplares similares

MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
por: Egeland, Nina Gran, et al.
Publicado: (2020)

Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index
por: Lea, Dordi, et al.
Publicado: (2021)

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients
por: Egeland, Nina Gran, et al.
Publicado: (2019)

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients
por: Egeland, Nina G., et al.
Publicado: (2015)

Prognostic Value of Gene Signatures and Proliferation in Lymph-Node-Negative Breast Cancer
por: Jonsdottir, Kristin, et al.
Publicado: (2014)

The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer
por: Klintman, Marie, et al.
Publicado: (2013)

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers
por: Jonsdottir, Kristin, et al.
Publicado: (2012)

The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer
por: Skaland, Ivar, et al.
Publicado: (2009)

Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients
por: Klebaner, Daniella, et al.
Publicado: (2017)

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients — an explorative study
por: Lende, Tone Hoel, et al.
Publicado: (2019)

Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark
por: Hjorth, Cathrine Fonnesbech, et al.
Publicado: (2021)

Correction: Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark
por: Hjorth, Cathrine Fonnesbech, et al.
Publicado: (2023)

Analysis of the Ki-67 index in the vaginal epithelium of castrated rats treated with tamoxifen
por: Nery-Aguiar, Afif Rieth, et al.
Publicado: (2016)

The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer
por: Hjorth, Cathrine F., et al.
Publicado: (2023)

Cell-cycle and Apoptosis Regulators (p16(INK4A), p21(CIP1), α-Catenin, Survivin, and hTERT) and Morphometry-Defined MPECs Predict Metachronous Cancer Development in Colorectal Adenoma Patients
por: Soreide, Kjetil, et al.
Publicado: (2007)

Application of p16/Ki-67 dual-staining cytology in cervical cancers
por: Yu, Li, et al.
Publicado: (2019)

The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening
por: Dovnik, Andraž, et al.
Publicado: (2023)

Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer
por: Watson, Martin M., et al.
Publicado: (2020)

Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark
por: Hjorth, Cathrine F., et al.
Publicado: (2022)

Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptors
por: de Sousa, Juarez Antônio, et al.
Publicado: (2006)

Automated Ki-67 Quantification of Immunohistochemical Staining Image of Human Nasopharyngeal Carcinoma Xenografts
por: Shi, Peng, et al.
Publicado: (2016)

A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment
por: Lea, Dordi, et al.
Publicado: (2021)

Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram
por: Lash, T L, et al.
Publicado: (2008)

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer
por: Lillesand, Melinda, et al.
Publicado: (2020)

LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer
por: Janssen, Emiel A. M., et al.
Publicado: (2009)

Content-based analysis of Ki-67 stained meningioma specimens for automatic hot-spot selection
por: Swiderska-Chadaj, Zaneta, et al.
Publicado: (2016)

Generative Adversarial Domain Adaptation for Nucleus Quantification in Images of Tissue Immunohistochemically Stained for Ki-67
por: Zhang, Xuhong, et al.
Publicado: (2020)

Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies
por: Uleberg, Kai-Erik, et al.
Publicado: (2011)

IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women
por: Joosten, Stacey E. P., et al.
Publicado: (2021)

Predict Ki-67 Positive Cells in H&E-Stained Images Using Deep Learning Independently From IHC-Stained Images
por: Liu, Yiqing, et al.
Publicado: (2020)

Interobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears
por: Kloboves Prevodnik, Veronika, et al.
Publicado: (2019)

p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening
por: Han, Qin, et al.
Publicado: (2020)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
por: Clarke, R. B., et al.
Publicado: (1993)

Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot
por: Beelen, Karin, et al.
Publicado: (2018)

Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study
por: Munk, Ane Cecilie, et al.
Publicado: (2012)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Prognostic Value of Immunohistochemical Staining of p53, bcl-2, and Ki-67 in Small Cell Lung Cancer
por: Paik, Kwang Hyun, et al.
Publicado: (2006)

Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
por: Ikenberg, Hans, et al.
Publicado: (2013)

Combination of Binary System with Ki67 Immunohistochemical Staining: a Reliable Grading Method for Oral Epithelial Dysplasia
por: Akafzadeh, Negar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hnaiv3q3j609vchpuirt07flb2